Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
3 Stocks With Positive Upgrades And How To InvestNick Chiu • Thu, Feb 28 -
-
-
-
-
Best In Class Healthcare And Biotech ETFsBarchart's ETF Recommendations • Tue, Sep 20, 2011 -
Biotechs: Revenues Rise, But So Do Cutbacks in R&DPharmalot • Mon, Aug 1, 2011 -
Narrowing Down the List of Biotech ETFs to 2 We'd RecommendMorningstar • Wed, Jun 22, 2011 -
-
-
-
The Search for Undervalued Sector ETFsMorningstar • Mon, Apr 18, 2011
-
-
PowerShares Goes to MexicoMichael Johnston • Thu, Mar 17, 2011 -
5 Biotechnology ETFs to Play InnovationTom Lydon • Wed, Feb 23, 2011
-
To learn more about Seeking Alpha Pro, click here.
-
Re-Evaluating Your Healthcare Exposure: A Sector ETF OverviewMorningstar • Thu, Mar 4, 2010
-
ETF Spotlight: PowerShares Dynamic Biotech & Genome (PBE)Tom Lydon • Fri, Jul 31, 2009
-
-
-
-
-
-
3 Stocks With Positive Upgrades And How To InvestNick Chiu • Thu, Feb 28
-
-
-
-
-
Best In Class Healthcare And Biotech ETFsBarchart's ETF Recommendations • Tue, Sep 20, 2011
-
Biotechs: Revenues Rise, But So Do Cutbacks in R&DPharmalot • Mon, Aug 1, 2011
-
Narrowing Down the List of Biotech ETFs to 2 We'd RecommendMorningstar • Wed, Jun 22, 2011
-
-
-
-
The Search for Undervalued Sector ETFsMorningstar • Mon, Apr 18, 2011
-
-
PowerShares Goes to MexicoMichael Johnston • Thu, Mar 17, 2011
-
5 Biotechnology ETFs to Play InnovationTom Lydon • Wed, Feb 23, 2011
-
There are no Transcripts on PBE.
-
at MarketWatch.com (Jun 20, 2011)
PBE vs. ETF Alternatives
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
See more details on sponsor's website
See more details on sponsor's website
Sector: Healthcare
Country: United States
Key Info
- In Your Portfolio: A Guide to Sector ETFs, A Guide to Healthcare, Pharma and Biotech ETFs
- Asset Class Performance: Sectors
